Applying to Clinical Trial: Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Contact this trialFirst, we need to learn more about you.

PD-L1 Inhibitor

Atezolizumab +3 More for Kidney Cancer

Recruiting1 awardPhase 2

Fort Wayne, Indiana

This trial is testing a new pill called IPI-549 combined with other drugs to treat advanced breast and kidney cancers. It aims to block cells that help tumors grow, boosting the body's immune response to fight the cancer.

Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.

We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our and

Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.

By clicking start, you agree to our